与Ic抗节律药物治疗相比,Ia型前节律失常的机制和危险因素
J H Levine1, J Morganroth, A H Kadish
1Division of Cardiology, St. Francis Hospital and Cardiac Center, Roslyn, New York 11576.
Circulation
|October 1, 1989
概括
抗心律不良药可以引起前节律不良,导致新的或恶化的心律不良. 不同类型的药物与不同类型的心律失常有关,例如类型Ia的torsades de pointes和类型Ic的腹腔性心力衰竭.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 电力生理学 电力生理学
背景情况:
- 前节律失常症,即抗节律药物诱导或加重心律失常症,是一个重大的临床问题.
- 了解药物诱导的心律失常的机制对于患者的安全至关重要.
研究的目的:
- 审查和分类的临床综合征的前节律失常.
- 提出不同类型的药物诱导性心律失常的潜在电生理机制.
- 为了解和管理临床前节律失常提供一个框架.
主要方法:
- 对临床数据和预发律不良的拟议电生理机制的审查.
- 基于临床表现和相关的抗心律不良药物类别的前节律事件的分类.
- 临床综合征与心律失常的拟议机制的相关性,例如触发活动和重新进入.
主要成果:
- 鉴定了由抗失律剂诱导的持续性心律失常的两个主要临床综合征:Torsades de Pointes (TdP) 和不停的,持续的,单态的,广泛复杂的心室高心率 (VT).
- Torsades de Pointes主要与Ia型抗失常药物有关,并通过早期脱极化后与触发活动相关.
- 发生的VT主要与Ic型药物有关,并与重新进入机制有关.
结论:
- 触发活动和重新进入的拟议机制为理解TdP和不间断的VT提供了合理的基础.
- 虽然这些分类提供了洞察力,但它们可能过于简单化,潜在的重叠和其他形式的前节律不完全解释.
- 需要进一步的研究,以完善对前节律失常机制的理解,特别是对于脑上节律失常和不太常见的表现.
相关概念视频
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...